UBXN11 and cancer: The results of our recent study, which examined the role of ET-1-activated CAFs in the early stages of SOC transcoelomic metastasis, indicated that the inhibition of ET-1 receptors could disrupt the interaction between SOC cells and CAFs, preventing the spread of cancer cells into the peritoneal cavity [7].